These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26530205)

  • 1. [Large vessel involvement in ANCA-associated vasculitis: Report of one case].
    Vega J; Guarda FJ
    Rev Med Chil; 2015 Sep; 143(9):1206-9. PubMed ID: 26530205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aortic Involvement in Antineutrophil Cytoplasmic Antibodies Vasculitis, a Coincidence or a Real Association?
    Tariq E; Nishanth K; Arshid A; Miqdad M; Cancarevic I
    Cureus; 2020 Aug; 12(8):e9690. PubMed ID: 32923282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rapidly progressive ANCA-negative glomerulonephritis in the course of pauci immune microscopic vasculitis with hemolytic anemia probable in the course of Wilson's disease].
    Wieczorek-Surdacka E; Kaczmarczyk I; Jasik P; Przepiórkowska-Hoyer B; Sułowicz W
    Przegl Lek; 2011; 68(2):123-5. PubMed ID: 21751523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of refractory aortitis in antineutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.
    Takenaka K; Ohba T; Suhara K; Sato Y; Nagasaka K
    Clin Rheumatol; 2014 Feb; 33(2):287-9. PubMed ID: 24357324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature.
    Chirinos JA; Tamariz LJ; Lopes G; Del Carpio F; Zhang X; Milikowski C; Lichtstein DM
    Clin Rheumatol; 2004 Apr; 23(2):152-9. PubMed ID: 15045631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
    Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
    BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic vasculitides classification].
    Guillevin L; Terrier B
    Presse Med; 2012 Oct; 41(10):986-95. PubMed ID: 22884126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic update in large vessel vasculitides.
    Pérez-Esteban S; González-Gay MA; Castañeda S
    Rev Clin Esp (Barc); 2013 Oct; 213(7):338-46. PubMed ID: 23683962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic vasculitides: a critical digest of the most recent literature.
    Stagnaro C; Cioffi E; Talarico R; Della Rossa A
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-145-54. PubMed ID: 26016767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and outcomes of ANCA-associated renal vasculitis.
    Seck SM; Dussol B; Brunet P; Burtey S
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):301-5. PubMed ID: 22382223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis and classification of microscopic polyangiitis.
    Kallenberg CG
    J Autoimmun; 2014; 48-49():90-3. PubMed ID: 24461388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study.
    Minz RW; Chhabra S; Joshi K; Rani L; Sharma N; Sakhuja V; Duggal R; Pasricha N
    Indian J Pathol Microbiol; 2012; 55(1):28-32. PubMed ID: 22499296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANCA-associated small vessel vasculitis (AASV) presenting as anemia and acute renal dysfunction.
    Shaikh Y; Ansari MJ
    Compr Ther; 2009; 35(3-4):192-5. PubMed ID: 20043616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biologic therapies in the systemic vasculitides].
    Díaz-Orta MA; Rojas-Serrano J
    Reumatol Clin; 2011 Dec; 7 Suppl 3():S33-6. PubMed ID: 22152288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.
    Gómez-Puerta JA; Quintana LF; Stone JH; Ramos-Casals M; Bosch X
    Autoimmun Rev; 2012 Jul; 11(9):646-52. PubMed ID: 22146313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis.
    Sinico RA; Di Toma L; Radice A
    Autoimmun Rev; 2013 Feb; 12(4):477-82. PubMed ID: 22921791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan.
    Kobayashi S; Fujimoto S; Takahashi K; Suzuki K
    Kidney Blood Press Res; 2010; 33(6):442-55. PubMed ID: 21071954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA glomerulonephritis associated with microscopic polyangiitis or Churg-Strauss syndrome.
    Richer C; Mouthon L; Cohen P; Buchet P; Royer I; Guettier C; Guillevin L
    Clin Nephrol; 1999 Jul; 52(1):47-50. PubMed ID: 10442496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.